IDF call to action for the UN High Level Meeting on NCDs 2018


IDF is currently involved in intensive advocacy efforts around the UN High Level Meeting (HLM) on NCDs that will take place in September 27, 2018, in New York. The HLM 2018 is the most important political meeting on diabetes and other NCDs to be held since 2014. 

Traditionally attended by Heads of State and Ministers of Health from around the world, the HLM 2018 will evaluate the global and national progress that governments have made since the last meeting in 2014 towards achieving the NCD-related targets included within the global Sustainable Development Goals (SDGs). These include achieving Universal Health Coverage (UHC) and reducing by one third premature deaths from NCDs by 2030. The meeting will result in a consensus document outlining the way forward in combating NCDs.

This is the moment to demand greater action at the national level to:

  • Achieve a 0% increase in diabetes prevalence by 2025.
  • Achieve 80% access to essential medicines and devices by 2025 and Universal Health Coverage (UHC) by 2030.
  • Achieve a 30% reduction in diabetes-related premature mortality by 2030.
  • Listen to the priorities of people with diabetes and defend their rights.

Why is it important to advocate around the UN HLM?

Despite global political commitments, many countries are off track to meet their targets. This means that the number of people with diabetes will continue to rise unabated. Without concerted action, IDF estimates that 100 million more people (522 million) will have diabetes by 2030 compared with 2017. For real change to happen at the national level, political action on diabetes is key. We need your support to bring global messages to your own country, so your national government understands that the time to act and protect the current and future generations from the impact of diabetes is now!

How to support the Campaign?

Develop your own national campaign

It will only be possible to achieve these objectives if the entire global diabetes community works together.

IDF has developed a series of materials that you can use to inform the development of a national advocacy campaign in support of IDF's call to action:

  • Advocacy toolkit
  • Template documents to be tailored according to national realities. These  include a letter explaining our call to action that you can edit and send to relevant policymakers from your country
  • 2-page summary of all the actions you can take at the global and national level.
HLM toolkit   2 pager   Call to action Letter policymakers Annexes
IDF HLM 2018
Diabetes Advocacy Toolkit
IDF HLM 2018
IDF HLM 2018
Call to Action
IDF HLM 2018
Editable letter
for policy makers
IDF HLM 2018
Toolkit Annexes

Please keep IDF informed of any advocacy activities relating to IDF HLM 2018 Call to Action by sending your updates to This email address is being protected from spambots. You need JavaScript enabled to view it..

Share a selfie in support of IDF's campaign

You can also support the IDF's call to action by sending us a selfie with a piece of paper, on which you would need to write: #HLM2018 + your diabetes priority for the next four years, using one of the following proposals:

YLD Paula Chinchilla

  • Improve prevention of diabetes complications
  • End discrimination against people with diabetes
  • Conduct T2D prevention initiatives
  • Defend the rights of people with diabetes
  • Improve diabetes education and awareness
  • Increase investment in diabetes care
  • Ensure access to affordable essential diabetes medicines and supplies
  • Increase budget for diabetes care and medicines
  • Improve access to quality diabetes care
  • Develop new funding mechanisms for diabetes care
  • Guarantee Universal Health Coverage
  • Engage and empower people with diabetes

Please then send your selfies to This email address is being protected from spambots. You need JavaScript enabled to view it.

Take a look at all the #HLM2018 selfies we have received so far: https://www.flickr.com/photos/idf/albums/72157692467574510

© 2018 International Diabetes Federation Disclaimer